Biotech · Private company
Regenesis Biomedical, Inc.
Track this companyFree. Adds Regenesis Biomedical, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- Active Provant Therapy SystemDiabetic Neuropathy PeripheralClinicalTrials.gov · fetched Nov 12, 2026
- Active Provant Therapy SystemDiabetic Peripheral NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- Inactive (sham) Provant Therapy SystemDiabetic Neuropathy PeripheralClinicalTrials.gov · fetched Nov 12, 2026
- Inactive (sham) Provant Therapy SystemDiabetic Peripheral NeuropathyClinicalTrials.gov · fetched Nov 12, 2026
- Provant Infinity Therapy SystemPostoperative PainClinicalTrials.gov · fetched Nov 12, 2026
- Provant Therapy SystemPainClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- An Open-Label Trial of PEMF Therapy [Provant Infinity Therapy System] for Home Use in Postoperative PainNA · WITHDRAWN · started Mar 1, 2020ClinicalTrials.gov NCT04300907 · fetched Nov 12, 2026
- Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral NeuropathyNA · COMPLETED · started Mar 26, 2018ClinicalTrials.gov NCT03455543 · fetched Nov 12, 2026
- Study of PEMF to Evaluate VPT and Thermal Sensory in Subjects With Diabetic Peripheral NeuropathyNA · COMPLETED · started Mar 9, 2017ClinicalTrials.gov NCT03077893 · fetched Nov 12, 2026
- A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain EtiologiesNA · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02881112 · fetched Nov 12, 2026